Literature DB >> 24146468

Quercetin: a potential natural drug for adjuvant treatment of rheumatoid arthritis.

Jian-Jun Ji1, Yuan Lin, Shan-Shan Huang, Hou-Li Zhang, Yun-Peng Diao, Kun Li.   

Abstract

Rheumatoid arthritis (RA) is the rheumatism mainly manifested as disabling joint disease and mainly involves hands, wrists, feet and other small joints. Recurrent arthritis attacks, synovial cell hypertrophy and hyperplasia and bone and cartilage damages eventually lead to joint dysfunction and other complications, and there is no cure. Quercetin (QU) is a kind of natural flavonoids, with lipid-lowering, anti-inflammatory and other pharmacological activities, and minor toxic side effects. Thus, we assume that QU may be an adjuvant natural drug for treatment of RA. The possible mechanism is through regulation of NF-κB, to inhibit the transcription of joint synovitis factors, hinder the generation of inflammatory factors, and inhibit the inflammatory reaction; through inhibiting the activities of VEGF, bFGF, MMP-2 and other cytokines, to inhibit angiogenesis in multiple links and inhibit synovial pannus formation. QU may be an adjuvant natural drug for treatment of RA.

Entities:  

Keywords:  natural drug; quercetin; rheumatoid arthritis

Mesh:

Substances:

Year:  2013        PMID: 24146468      PMCID: PMC3777580     

Source DB:  PubMed          Journal:  Afr J Tradit Complement Altern Med        ISSN: 2505-0044


  22 in total

1.  In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis.

Authors:  H Sano; T Hla; J A Maier; L J Crofford; J P Case; T Maciag; R L Wilder
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

2.  Multiple nuclear factors interact with the immunoglobulin enhancer sequences.

Authors:  R Sen; D Baltimore
Journal:  Cell       Date:  1986-08-29       Impact factor: 41.582

3.  Quercetin attenuates nuclear factor-kappaB activation and nitric oxide production in interleukin-1beta-activated rat hepatocytes.

Authors:  Susana Martínez-Flórez; Belén Gutiérrez-Fernández; Sonia Sánchez-Campos; Javier González-Gallego; María J Tuñón
Journal:  J Nutr       Date:  2005-06       Impact factor: 4.798

4.  Therapeutic and preventive properties of quercetin in experimental arthritis correlate with decreased macrophage inflammatory mediators.

Authors:  Maria Mamani-Matsuda; Tina Kauss; Abir Al-Kharrat; Jérôme Rambert; Fawaz Fawaz; Denis Thiolat; Daniel Moynet; Sara Coves; Denis Malvy; M Djavad Mossalayi
Journal:  Biochem Pharmacol       Date:  2006-09-07       Impact factor: 5.858

Review 5.  Nitric oxide and inflammatory arthritides.

Authors:  N Miyasaka; Y Hirata
Journal:  Life Sci       Date:  1997       Impact factor: 5.037

6.  Quercetin suppresses proinflammatory cytokines production through MAP kinases andNF-kappaB pathway in lipopolysaccharide-stimulated macrophage.

Authors:  Sung-Yeon Cho; Sang-Joon Park; Myung-Ja Kwon; Tae-Sook Jeong; Song-Hae Bok; Woo-Young Choi; Won-Il Jeong; Si-Yun Ryu; Sun-Hee Do; Cha-Soo Lee; Jae-Chan Song; Kyu-Shik Jeong
Journal:  Mol Cell Biochem       Date:  2003-01       Impact factor: 3.396

7.  Localization of vascular endothelial growth factor in synovial membrane mast cells: examination with "multi-labelling subtraction immunostaining".

Authors:  T Yamada; M Sawatsubashi; H Yakushiji; Y Itoh; G Edakuni; M Mori; L Robert; K Miyazaki
Journal:  Virchows Arch       Date:  1998-12       Impact factor: 4.064

Review 8.  Evolving concepts of rheumatoid arthritis.

Authors:  Gary S Firestein
Journal:  Nature       Date:  2003-05-15       Impact factor: 49.962

9.  Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study.

Authors:  M G Hertog; D Kromhout; C Aravanis; H Blackburn; R Buzina; F Fidanza; S Giampaoli; A Jansen; A Menotti; S Nedeljkovic
Journal:  Arch Intern Med       Date:  1995-02-27

10.  Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition.

Authors:  D R Ferry; A Smith; J Malkhandi; D W Fyfe; P G deTakats; D Anderson; J Baker; D J Kerr
Journal:  Clin Cancer Res       Date:  1996-04       Impact factor: 12.531

View more
  5 in total

Review 1.  Recent development in antihyperalgesic effect of phytochemicals: anti-inflammatory and neuro-modulatory actions.

Authors:  Ajeet Kumar Singh; Sanjay Kumar; Manjula Vinayak
Journal:  Inflamm Res       Date:  2018-05-16       Impact factor: 4.575

Review 2.  Anti-rheumatic effect of quercetin and recent developments in nano formulation.

Authors:  Feng Guan; Qi Wang; Yongping Bao; Yimin Chao
Journal:  RSC Adv       Date:  2021-02-11       Impact factor: 3.361

Review 3.  Natural medicines of targeted rheumatoid arthritis and its action mechanism.

Authors:  Xueling Liu; Zhiguo Wang; Hua Qian; Wenhua Tao; Ying Zhang; Chunyan Hu; Weiwei Mao; Qi Guo
Journal:  Front Immunol       Date:  2022-08-01       Impact factor: 8.786

Review 4.  Angiomodulatory properties of Rhodiola spp. and other natural antioxidants.

Authors:  Dorota M Radomska-Leśniewska; Piotr Skopiński; Barbara J Bałan; Agata Białoszewska; Jarosław Jóźwiak; Dariusz Rokicki; Ewa Skopińska-Różewska; Anna Borecka; Agata Hevelke
Journal:  Cent Eur J Immunol       Date:  2015-08-03       Impact factor: 2.085

Review 5.  Natural Products for the Treatment of Autoimmune Arthritis: Their Mechanisms of Action, Targeted Delivery, and Interplay with the Host Microbiome.

Authors:  Steven Dudics; David Langan; Rakeshchandra R Meka; Shivaprasad H Venkatesha; Brian M Berman; Chun-Tao Che; Kamal D Moudgil
Journal:  Int J Mol Sci       Date:  2018-08-24       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.